Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02501096 |
|---|---|
| Brief Title: | A Trial of Lenvatinib (E7080) Plus Pembrolizumab in Participants With Selected Solid Tumors |
| First Submitted : | July 15, 2015 |
| First Submitted that Met QC Criteria : | July 15, 2015 |
| First Posted : | July 17, 2015 (Estimate) |
| Results First Submitted : | June 9, 2023 |
| Results First Submitted that Met QC Criteria : | July 14, 2023 |
| Results First Posted : | July 20, 2023 |
| Certification/Extension First Submitted : | June 11, 2021 |
| Certification/Extension First Submitted that Met QC Criteria : | June 11, 2021 |
| Certification/Extension First Posted : | June 14, 2021 |
| Last Update Submitted that Met QC Criteria : | July 14, 2023 |
| Last Update Posted : | July 20, 2023 |